Regulation of memory CD8 T-cell differentiation by cyclin-dependent kinase inhibitor p27Kip1

Anju Singh1, Anna Jatzek, Erin Hemmila Plisch

  • 1Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI 53706, USA.

Insights

The cyclin-dependent kinase inhibitor p27(Kip1) regulates CD8 T-cell memory formation. Removing p27(Kip1) enhances T-cell memory and recall responses, improving vaccine efficacy.

Area of Science:

  • Immunology
  • Cell Biology
  • Vaccinology

Background:

  • T-cell memory is crucial for effective vaccination.
  • Molecular mechanisms controlling CD8 T-cell memory formation are not fully understood.
  • Cell cycle regulation of CD8 T-cell proliferation and survival during immune responses is poorly defined.

Purpose of the Study:

  • To identify molecular regulators of CD8 T-cell homeostasis and memory formation.
  • To investigate the role of cell cycle regulators in CD8 T-cell responses to viral infection.
  • To determine the impact of p27(Kip1) on T-cell memory magnitude and quality.

Main Methods:

  • Studied CD8 T-cell responses in mice during acute viral infection.
  • Utilized genetic models to investigate the function of p27(Kip1).
  • Assessed T-cell proliferation, apoptosis, and memory recall responses.

Main Results:

  • Identified p27(Kip1) as a critical regulator of CD8 T-cell homeostasis.
  • p27(Kip1) acts as a timer for cell cycle exit, limiting memory precursor expansion.
  • Absence of p27(Kip1) resulted in enhanced CD8 T-cell memory and recall responses, particularly effector memory cells.

Conclusions:

  • p27(Kip1) critically controls CD8 T-cell homeostasis and memory formation.
  • Modulating p27(Kip1) can enhance vaccine-induced T-cell memory and protective immunity.
  • Findings provide insights into cell cycle regulation of T-cell memory.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.